# Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study

> **NCT00223223** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 30 (—)

## Conditions studied

- Memory Loss Associated With Corticosteroid Use
- Manic State Associated With Corticosteroid Use

## Interventions

- **DRUG:** Levetiracetam, Keppra

## Key facts

- **NCT ID:** NCT00223223
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 30 (—)
- **Last updated:** 2011-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00223223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00223223, "Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00223223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*